RO-7020322

N/A

Report date: 2025/03/19 14:45:49
NME

Base Information

Drug NameRO-7020322
Drug Alias NameRG-7834RO-7020322
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTerminal nucleotidyltransferase 4B inhibitorsTerminal nucleotidyltransferase 4A inhibitors
TargetsTerminal nucleotidyltransferase 4BTerminal nucleotidyltransferase 4A
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanNew ZealandHong Kong +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B, ChronicHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A